Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 23 2014
Print

Mylan Appoints Emerging Markets President



By Kristin Brooks



Published January 3, 2014
Rakesh Bamzai has been appointed president, India Commercial and Emerging Markets at Mylan, Inc. Mr. Bamzai has more than 20 years of experience in the Indian and global biopharmaceutical industry.
 
Prior to joining the company, he served as president of marketing at Biocon, where he had overall responsibility for APIs and branded formulations and managed a team of more than 2,000 people across functional areas and geographies. He also oversaw strategic partnerships that enabled the company to gain greater global access and market penetration for its biopharmaceuticals business. Mr. Bamzai also led Biocon's branded formulations initiatives, building many successful brands across therapies in India and Gulf Cooperation Council states.
 
Mylan president Rajiv Malik, said, "We were extremely pleased when Rakesh asked to join our company. Many of us at Mylan have had a firsthand opportunity to work with Rakesh over the course of our strategic partnership with Biocon and have observed his strong business and marketing acumen, his strategic insight and outstanding leadership skills. In this new role overseeing all of Mylan's commercial operations in India and emerging markets, we believe that Rakesh will add significant value to Mylan."


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On